Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Sleep in Shift Workers
NCT05344443Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lemborexant in circadian rhythm sleep-wake disorder (CRSWD), sponsored by University of California, San Francisco. Started Mar 2022; status: completed.
02
Drugs
lemborexant
03
Conditions
circadian rhythm sleep-wake disorder (CRSWD)
Beyond the preview
Go deeper on NCT05344443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05344443.